+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Advances in Immunology, Vol 142

  • ID: 4746021
  • Book
  • July 2019
  • Region: Global
  • 148 Pages
  • Elsevier Science and Technology
1 of 3

Advances in Immunology, Volume 142, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this release focusing on the advancing area of the mechanisms involved in the evolution of HIV-1 neutralizing antibodies.

  • Presents current developments and comprehensive reviews in immunology
  • Provides the latest in a longstanding, respected serial on the subject matter
  • Focuses on recent advances in the advancing area of the mechanisms involved in the evolution of HIV-1 neutralizing antibodies

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 3
1. The airway epithelium in asthma Luke R. Bonser and David J. Erle 2. Deconstructing the sex bias in allergy and autoimmunity: From sex hormones and beyond Sophie Laffont and Jean-Charles Guéry 3. Roles of cysteinyl leukotrienes and their receptors in immune cell-related functions Yoshihide Kanaoka and K. Frank Austen 4. Airway mycosis in allergic airway disease Evan Li, J. Morgan Knight, Yifan Wu, Amber Luong, Antony Rodriguez, Farrah Kheradmand and David B. Corry
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Alt, Frederick W.
Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
Note: Product cover images may vary from those shown
Adroll
adroll